Webster K Cavenee Selected Research

Webster K Cavenee Research Topics

Disease

86	Neoplasms (Cancer) 05/2022 - 01/2002
55	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 11/2002
25	Glioma (Gliomas) 12/2019 - 01/2002
16	Brain Neoplasms (Brain Tumor) 12/2019 - 05/2009
7	Melanoma (Melanoma, Malignant) 12/2021 - 08/2010
6	Carcinogenesis 01/2020 - 02/2012
5	Neoplasm Metastasis (Metastasis) 12/2021 - 01/2015
3	Leukemia 01/2020 - 03/2013
2	Prostatic Neoplasms (Prostate Cancer) 10/2017 - 07/2015
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2014 - 02/2007
2	Genomic Instability 08/2011 - 05/2010
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2019

Drug/Important Bio-Agent (IBA)

29	ErbB Receptors (EGF Receptor)IBA 01/2017 - 01/2002
27	epidermal growth factor receptor VIIIIBA 01/2019 - 03/2002
12	Proteins (Proteins, Gene)FDA Link 05/2022 - 11/2007
11	Mechanistic Target of Rapamycin Complex 2IBA 01/2020 - 11/2011
9	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2008
9	Phosphotransferases (Kinase)IBA 10/2013 - 01/2005
7	Pharmaceutical PreparationsIBA 01/2021 - 01/2014
7	Tyrosine (L-Tyrosine)FDA Link 12/2019 - 12/2011
6	SynteninsIBA 01/2021 - 10/2017
6	LigandsIBA 01/2020 - 01/2002
6	Growth Factor ReceptorsIBA 12/2019 - 01/2005
6	Monoclonal AntibodiesIBA 01/2011 - 03/2002
5	Histones (Histone)IBA 01/2020 - 08/2011
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2019 - 09/2006
5	AntibodiesIBA 03/2009 - 01/2002
4	EnzymesIBA 05/2022 - 02/2019
4	Biological ProductsIBA 12/2021 - 05/2013
4	SyndecansIBA 01/2021 - 10/2017
4	Carrier Proteins (Binding Protein)IBA 01/2021 - 10/2017
4	TOR Serine-Threonine KinasesIBA 01/2020 - 01/2005
4	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 12/2017 - 02/2005
4	Tyrosine Kinase InhibitorsIBA 01/2015 - 01/2011
3	LipidsIBA 05/2022 - 09/2006
3	Mechanistic Target of Rapamycin Complex 1IBA 01/2020 - 10/2013
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2019 - 01/2013
3	Sirolimus (Rapamycin)FDA Link 02/2019 - 08/2006
3	CytokinesIBA 01/2019 - 01/2017
3	Transcription Factors (Transcription Factor)IBA 10/2015 - 07/2003
3	monoclonal antibody 806IBA 09/2009 - 03/2002
2	InterleukinsIBA 12/2021 - 01/2019
2	Lysine (L-Lysine)FDA Link 04/2021 - 01/2020
2	IronIBA 12/2019 - 01/2011
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 02/2019 - 07/2016
2	MicroRNAs (MicroRNA)IBA 01/2019 - 12/2013
2	EpitopesIBA 01/2019 - 01/2006
2	ChromatinIBA 01/2018 - 12/2017
2	TensinsIBA 12/2017 - 08/2012
2	Long Noncoding RNAIBA 10/2017 - 07/2015
2	Glucose (Dextrose)FDA LinkGeneric 07/2015 - 09/2011
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 05/2013 - 04/2003
2	Epidermal Growth Factor (EGF)IBA 02/2013 - 01/2004
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 08/2012 - 09/2006
2	src-Family KinasesIBA 02/2012 - 09/2009
2	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 02/2012 - 12/2011
2	Protein Kinases (Protein Kinase)IBA 11/2011 - 05/2009
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2011 - 11/2002
2	PhosphotyrosineIBA 03/2011 - 07/2010
2	Peptides (Polypeptides)IBA 01/2011 - 01/2006
2	Death Domain ReceptorsIBA 03/2007 - 01/2002
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2006 - 11/2005
1	NucleotidesIBA 05/2022
1	Interleukin-10 (Interleukin 10)IBA 12/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	IntegrinsIBA 01/2020
1	Lumefantrine FDA Link 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 01/2020
1	Antimalarials (Antimalarial Agents)IBA 01/2020
1	1-(1-mercaptocyclohexaneacetic acid)-2-(O- methyl-L-tyrosine)-8-L-arginine- vasopressin (AAVP)IBA 01/2020
1	Pyruvic Acid (Pyruvate)IBA 12/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2019
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 12/2019
1	Oxidoreductases (Dehydrogenase)IBA 12/2019
1	1-Acylglycerophosphocholine O-Acyltransferase (1 Acylglycerophosphocholine O Acyltransferase)IBA 01/2019
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2019
1	Membrane LipidsIBA 01/2019
1	Surface Antigens (Surface Antigen)IBA 01/2019
1	NestinIBA 01/2019
1	Cell-Free Nucleic AcidsIBA 01/2019
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2019
1	CarcinogensIBA 11/2018
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 12/2017
1	Interleukin-13 Receptor alpha2 SubunitIBA 12/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	SurvivinIBA 01/2017
1	Inhibitor of Apoptosis ProteinsIBA 01/2017
1	CaspasesIBA 01/2017
1	Mutant Proteins (Protein, Mutant)IBA 01/2017
1	poly(malic acid)IBA 12/2016
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2016

Therapy/Procedure

41	Therapeutics 12/2021 - 01/2002
7	Drug Therapy (Chemotherapy) 01/2021 - 05/2009
3	Radiotherapy 10/2017 - 05/2009
1	Aftercare (After-Treatment) 01/2020
1	Precision Medicine 11/2018
1	Injections 01/2018
1	Oncolytic Virotherapy 01/2017